Business Description
Zelira Therapeutics Ltd
NAICS : 212221
ISIN : AU000000ZLD1
Description
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | -0.87 | |||||
| Debt-to-Equity | -1.32 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -45.05 | |||||
| Beneish M-Score | -593.96 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -50.3 | |||||
| 3-Year EBITDA Growth Rate | -37.2 | |||||
| 3-Year EPS without NRI Growth Rate | 27.3 | |||||
| 3-Year FCF Growth Rate | 33.2 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.79 | |||||
| 9-Day RSI | 41.59 | |||||
| 14-Day RSI | 41.41 | |||||
| 6-1 Month Momentum % | 53.13 | |||||
| 12-1 Month Momentum % | -27.94 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | |||||
| Quick Ratio | 0.42 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 6050.02 | |||||
| Days Sales Outstanding | 876 | |||||
| Days Payable | 12512.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.6 | |||||
| Shareholder Yield % | -67.23 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.58 | |||||
| Operating Margin % | -6250.53 | |||||
| Net Margin % | -38493.68 | |||||
| FCF Margin % | -4618.95 | |||||
| ROE % | -439.78 | |||||
| ROA % | -259.34 | |||||
| ROIC % | -45.13 | |||||
| ROC (Joel Greenblatt) % | -9482 | |||||
| ROCE % | -381.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 72.22 | |||||
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.36 | |||||
| EV-to-Revenue | 131.1 | |||||
| EV-to-FCF | -2.93 | |||||
| Earnings Yield (Greenblatt) % | -286.63 | |||||
| FCF Yield % | -61.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zelira Therapeutics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.095 | ||
| EPS (TTM) (A$) | -3.223 | ||
| Beta | 1.12 | ||
| Volatility % | 113.64 | ||
| 14-Day RSI | 41.41 | ||
| 14-Day ATR (A$) | 0.027208 | ||
| 20-Day SMA (A$) | 0.679 | ||
| 12-1 Month Momentum % | -27.94 | ||
| 52-Week Range (A$) | 0.28 - 1.09 | ||
| Shares Outstanding (Mil) | 11.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zelira Therapeutics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zelira Therapeutics Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zelira Therapeutics Ltd Frequently Asked Questions
What is Zelira Therapeutics Ltd(ASX:ZLD)'s stock price today?
The current price of ASX:ZLD is A$0.65. The 52 week high of ASX:ZLD is A$1.09 and 52 week low is A$0.28.
When is next earnings date of Zelira Therapeutics Ltd(ASX:ZLD)?
The next earnings date of Zelira Therapeutics Ltd(ASX:ZLD) is .
Does Zelira Therapeutics Ltd(ASX:ZLD) pay dividends? If so, how much?
Zelira Therapeutics Ltd(ASX:ZLD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers